Raising funds through shares, convertible bonds and stock acquisition rights for growth investments, including M&A
First written in FY2016. 21 of 26 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.
25 other companies' latest entry also says "Other".
- FY2026Reduction of interest-bearing debt through repayment of borrowingsAnnual report
「During the consolidated fiscal year, the company raised ¥339.911 million in long-term borrowings and ¥50.000 million through bond issuance, primarily for working capital. At the same time, it repaid ¥747.059 million in long-term borrowings and reduced short-term borrowings by ¥115.000 million on a net basis, as well as redeeming ¥14.000 million in bonds, thereby reducing interest-bearing debt.」
While raising funds through long-term borrowings and bonds, the company repaid ¥747.059 million in long-term borrowings and other amounts, reducing interest-bearing debt. - FY2026-H1AdvancedAnnual report
「Net cash provided by financing activities was ¥261.322 million. This was mainly because funds increased by a ¥395.000 million increase in short-term borrowings and proceeds of ¥120.000 million from long-term borrowings, while funds decreased by repayments of long-term borrowings of ¥272.688 million and expenditures of ¥14.688 million for the acquisition of shares in a subsidiary without a change in the scope of consolidation.」
Regarding its policy of using borrowings and bonds in addition to new share issuance and other measures, the company raised funds during the interim period through ¥395.000 million in short-term borrowings, ¥120.000 million in long-term borrowings and ¥50.000 million from bond issuance, while repaying ¥272.688 million in long-term borrowings. - FY2025AdvancedAnnual report
「During the consolidated fiscal year, the company raised ¥232.000 million on a net basis in short-term borrowings and ¥600.000 million in long-term borrowings from financial institutions, primarily for working capital, while repaying ¥465.243 million in long-term borrowings.」
Regarding its policy of using borrowings in addition to new share issuance and other measures, the company raised ¥232.000 million in short-term borrowings and ¥600.000 million in long-term borrowings, while repaying ¥465.243 million in long-term borrowings. - FY2025-H1AdvancedAnnual report
「Net cash provided by financing activities was ¥378.836 million. This was mainly because funds increased by a ¥652.000 million increase in short-term borrowings, while funds decreased by repayments of long-term borrowings of ¥241.051 million and dividend payments of ¥49.647 million.」
Regarding its policy of using borrowings in addition to new share issuance and other measures, the company raised funds through borrowings during the interim period, including a ¥652.000 million increase in short-term borrowings. - FY2024AdvancedAnnual report
「During the consolidated fiscal year, the company raised ¥1,028.000 million in short-term borrowings and ¥210.000 million in long-term borrowings from financial institutions, primarily for working capital.」
The company reported that, in addition to new share issuance, its capital policy uses borrowings and other methods, and that it raised ¥1,028.000 million in short-term borrowings and ¥210.000 million in long-term borrowings during the period. - FY2023-Q3AdvancedAnnual report
「Non-current liabilities totaled ¥1,923.877 million, an increase of ¥779.373 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥795.532 million increase in long-term borrowings from bank loans.」
Regarding funding, including growth capital for M&A and other purposes, long-term borrowings increased by ¥795.532 million through bank loans, advancing fundraising through borrowings. - FY2021RestatedAnnual report
「Our basic capital policy is to return profits to shareholders through dividends and make the investments necessary for future growth while taking financial soundness into consideration. Specifically, we generally fund working capital, capital expenditures and research and development activities from internal funds, while for funding needs such as large-scale capital expenditures and M&A that cannot be covered solely by internal funds, we intend to consider financing methods including the issuance of new shares and borrowings.」
The company reaffirmed its capital policy of using new share issuance and borrowings for large-scale investments and M&A while relying primarily on internal funds. During the period, it recorded ¥765.000 million in long-term borrowings and other funding. - FY2021-Q3AdvancedAnnual report
「Non-current liabilities totaled ¥1,797.479 million, an increase of ¥647.218 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥83.000 million in bonds and ¥524.570 million in long-term borrowings resulting from fundraising by subsidiaries. The increase in long-term borrowings was intended to build up cash on hand in preparation for the impact of COVID-19 and further strengthen the stability of the financial base.」
In addition to stock acquisition rights and other measures, subsidiaries raised ¥83.000 million through bonds and ¥524.570 million through long-term borrowings, strengthening cash on hand and the financial base in preparation for the impact of the infection. - FY2021-Q2AdvancedAnnual report
「Net cash provided by financing activities was ¥489.117 million, compared with ¥345.973 million in the same period of the previous year. This was mainly because funds increased by proceeds of ¥98.890 million from the issuance of bonds and ¥765.000 million from long-term borrowings, while funds decreased by repayments of short-term borrowings of ¥150.000 million, repayments of long-term borrowings of ¥135.276 million and repayments of long-term accounts payable of ¥57.805 million.」
In addition to the exercise of stock acquisition rights, the company recorded funds raised through ¥98.890 million in bonds and ¥765.000 million in long-term borrowings, advancing fundraising including borrowings and bonds. - FY2021-Q1AdvancedAnnual report
「Non-current liabilities totaled ¥1,283.008 million, an increase of ¥132.747 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥78.935 million increase in long-term borrowings. The increase in long-term borrowings was intended to build up cash on hand in preparation for the impact of COVID-19 and further strengthen the stability of the financial base.」
In addition to new share issuance and other measures, the company increased long-term borrowings by ¥78.935 million to prepare for the impact of the infection, strengthening cash on hand and its financial base. - FY2020Expansion to funding methods including borrowings and bondsAnnual report
「Our basic capital policy is to make the investments necessary for future growth while taking financial soundness into consideration. Specifically, we generally fund working capital, capital expenditures and research and development activities from internal funds, while for funding needs such as M&A that cannot be covered solely by internal funds, we intend to consider financing methods including the issuance of new shares and borrowings.」
The company clearly stated its policy of using borrowings and other financing methods in addition to new share issuance for growth funding, including M&A, and during the period raised ¥492.554 million through bonds as well as funds through short- and long-term borrowings. - FY2020-Q3AdvancedAnnual report
「Non-current liabilities totaled ¥931.235 million, an increase of ¥474.640 million from the end of the previous consolidated fiscal year. This was mainly due to a ¥50.305 million decrease in long-term accounts payable as a result of its reclassification to accounts payable, while bonds increased by ¥280.000 million and long-term borrowings by ¥225.627 million, respectively, due to fundraising by a subsidiary and the consolidation of TGM as a subsidiary.」
In addition to funds raised through the exercise of stock acquisition rights, bonds increased by ¥280.000 million and long-term borrowings by ¥225.627 million in connection with fundraising by a subsidiary and the consolidation of TGM as a subsidiary. - FY2020-Q2Additional fundraising through bonds and borrowingsAnnual report
「Net cash provided by financing activities was ¥345.973 million, compared with net cash used of ¥29.912 million in the same period of the previous year. This was mainly because funds increased by proceeds of ¥300.000 million from the issuance of bonds and ¥200.000 million from long-term borrowings, while funds decreased by repayments of long-term borrowings of ¥72.411 million and repayments of long-term accounts payable of ¥57.805 million.」
In addition to fundraising through the exercise of existing stock acquisition rights, the company raised funds during the quarter through the issuance of ¥300 million in bonds and ¥200 million in long-term borrowings. It also issued 2,000 stock acquisition rights equivalent to 200,000 shares to directors and directors of subsidiaries, with an exercise period from 19 September 2019 to 18 September 2029. There is no statement that the use of these funds is limited to M&A. - FY2020-Q1AdvancedAnnual report
「During the first-quarter accounting period, stock acquisition rights attached to bonds with stock acquisition rights subject to exercise-price adjustment clauses were exercised as follows.」
During the quarter, 11 stock acquisition rights were exercised, 11,000 shares were issued and ¥4.885 million was raised. Cumulative figures through the end of the quarter were 2,726 warrants and ¥1,293.551 million raised. - FY2019AdvancedAnnual report
「Net cash provided by financing activities was ¥193.519 million, compared with ¥1,044.975 million in the same period of the previous year. The main factors were proceeds of ¥254.602 million from short- and long-term borrowings, repayments of long-term borrowings of ¥460.712 million, repayments of long-term accounts payable of ¥57.805 million, and proceeds of ¥474.710 million from the issuance of shares upon exercise of stock acquisition rights.」
The company recorded ¥474.710 million in proceeds from the issuance of shares upon exercise of stock acquisition rights, advancing fundraising during the period. Cumulative funds raised totaled ¥1,504.666 million. - FY2019-Q3AdvancedAnnual report
「During the third quarter, share acquisition rights relating to bonds with share acquisition rights and other instruments with an exercise price adjustment clause were exercised as follows.」
In the third-quarter accounting period, 281 warrants were exercised, 281,000 shares were issued and ¥131.686 million was raised. Cumulative figures through the end of the quarter were 2,486 warrants and ¥1,186.974 million raised. - FY2019-Q2AdvancedAnnual report
「Net cash used in financing activities was ¥29.912 million, compared with ¥151.872 million provided in the same period of the previous year. The main factors were ¥204.602 million in total proceeds from short-term and long-term borrowings, ¥409.752 million used for repayment of long-term borrowings, ¥57.805 million used for repayment of long-term accounts payable, and ¥241.332 million in proceeds from the issuance of shares through the exercise of share acquisition rights.」
Proceeds of ¥241.332 million from the issuance of shares through the exercise of share acquisition rights were recorded. During the second quarter, 2,000 shares were delivered, bringing cumulative funding to ¥1,055.288 million. - FY2019-Q1AdvancedAnnual report
「Net assets totaled ¥4,465.022 million, an increase of ¥123.196 million from the end of the previous consolidated fiscal year. This was mainly due to increases of ¥119.445 million each in share capital and capital surplus resulting from the exercise of share acquisition rights, the recognition of a quarterly net loss attributable to owners of the parent of ¥16.231 million, and a ¥93.671 million decrease in the valuation difference on available-for-sale securities.」
The exercise of share acquisition rights progressed in the first quarter, increasing share capital and capital surplus by ¥119.445 million each. - FY2018-Q3AdvancedAnnual report
「During the third quarter, share acquisition rights relating to bonds with share acquisition rights and other instruments with an exercise price adjustment clause were exercised as follows.」
In the third quarter, 242 share acquisition rights were exercised, 242,000 shares were issued, and ¥130.628 million in funding was recorded. By the end of the quarter, share capital and capital reserves had each increased by ¥175.402 million. - FY2018-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 11 October 2017, we resolved to issue the fifth series of share acquisition rights with an exercise price adjustment clause through a third-party allotment, as described below, and issued them on 27 October 2017. Use of proceeds: Future M&A and capital and business alliances」
We issued the fifth series of share acquisition rights to fund future M&A and capital and business alliances. The number of potential shares was 3,500,000, the amount to be raised at the initial exercise price was ¥2,215.5 million, and the exercise period was from 30 October 2017 to 29 October 2019. We also acquired and cancelled the 6,820 unexercised units of the previously issued fourth series of share acquisition rights, changing the funding method. - FY2018-Q1AdvancedAnnual report
「This was mainly due to a total ¥218.970 million increase in share capital and capital surplus resulting from the exercise of share acquisition rights.」
The exercise of share acquisition rights progressed in the first quarter, increasing share capital and capital surplus by a total of ¥218.970 million. - FY2017AdvancedAnnual report
「Funds used in financing activities totaled ¥27.298 million, compared with ¥157.921 million provided in the previous fiscal year. This was due to ¥46.415 million in proceeds from the issuance of shares through the exercise of share acquisition rights, offset by ¥15.908 million used for repayment of lease liabilities and ¥57.805 million used for repayment of long-term accounts payable.」
Proceeds of ¥46.415 million from the issuance of shares through the exercise of share acquisition rights were recorded during the year, indicating progress in funding and capitalization through previously issued share acquisition rights and other instruments. - FY2017-Q3AdvancedAnnual report
「This was mainly due to increases of ¥35.554 million each in share capital and capital surplus resulting from the conversion of bonds with share acquisition rights that are convertible bonds and the exercise of share acquisition rights, offset by the recognition of a quarterly net loss attributable to owners of the parent of ¥8.540 million, a ¥44.194 million decrease in the valuation difference on available-for-sale securities, and a ¥4.693 million decrease resulting from the exercise of share acquisition rights.」
The conversion of issued bonds with share acquisition rights that are convertible bonds and the exercise of share acquisition rights progressed further, increasing share capital and capital surplus by ¥35.554 million each. - FY2017-Q2AdvancedAnnual report
「Net cash used in financing activities was ¥20.100 million, compared with ¥73.508 million used in the same period of the previous year. This resulted from ¥57.805 million used for repayment of long-term accounts payable, ¥46.415 million in proceeds from the issuance of shares through the exercise of share acquisition rights, and ¥8.710 million in other expenditures.」
Proceeds of ¥46.415 million from the issuance of shares through the exercise of share acquisition rights were recorded, indicating progress in funding through the previously issued share acquisition rights and other instruments. - FY2017-Q1AdvancedAnnual report
「This was mainly due to increases of ¥29.464 million each in share capital and capital surplus resulting from the conversion of bonds with share acquisition rights that are convertible bonds and the exercise of share acquisition rights, offset by the recognition of a quarterly net loss attributable to owners of the parent of ¥37.222 million and a ¥40.545 million decrease in the valuation difference on available-for-sale securities.」
The conversion of issued bonds with share acquisition rights that are convertible bonds and the exercise of share acquisition rights progressed, increasing share capital and capital surplus by ¥29.464 million each. - FY2016First statedAnnual report
「On 17 December of the previous year, we issued “new shares, bonds with share acquisition rights that are convertible bonds, and share acquisition rights” as growth capital for future M&A and other purposes, raising ¥291 million.」
A total of ¥291 million was raised as funding for future growth investments, including M&A.